Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Zaire”

25 trials

Showing 20 of 25 results

Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Not applicableStudy completedNCT02933931
What this trial is testing

Immune Durability After VSV-EBOV Vaccination

Who this might be right for
Immune ResponseVaccinationDurability
University Hospital, Geneva 95
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Testing effectiveness (Phase 2)Study completedNCT02289027
What this trial is testing

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Who this might be right for
Ebola Vaccines
Centre Hospitalier Universitaire Vaudois 120
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Testing effectiveness (Phase 2)Study completedNCT02344407
What this trial is testing

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Early research (Phase 1)Study completedNCT02240875
What this trial is testing

Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Who this might be right for
EbolaEbola Zaire
University of Oxford 91
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Testing effectiveness (Phase 2)Study completedNCT04186000
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Who this might be right for
Ebola Virus Disease
Universiteit Antwerpen 699
Large-scale testing (Phase 3)Study completedNCT03719586
What this trial is testing

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 681
Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT04409405
What this trial is testing

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 787
Early research (Phase 1)UnknownNCT05301504
What this trial is testing

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 76
Post-approval studies (Phase 4)Looking for participantsNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Testing effectiveness (Phase 2)Study completedNCT02287480
What this trial is testing

VSV-ZEBOV Geneva Vaccine Trial

Who this might be right for
Ebolavirus Disease
University Hospital, Geneva 115
Testing effectiveness (Phase 2)Study completedNCT02548078
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 600
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 99
Large-scale testing (Phase 3)UnknownNCT04152486
What this trial is testing

Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 20,426
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation